(Q52106457)

22 April 2018

title

Visual evoked potentials in Alzheimer's disease: correlations with age and severity (English)

1 reference

https://api.crossref.org/works/10.1016/0168-5597(90)90053-G

1 November 2022

1 reference

M. P. Philpot

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1697523

1 November 2022

D. Amin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1697523

1 November 2022

R. Levy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1697523

1 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1697523

1 November 2022

publication date

1 September 1990

1 reference

22 April 2018

full work available at URL

https://api.elsevier.com/content/article/PII:016855979090053G?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0168-5597(90)90053-G

https://api.elsevier.com/content/article/PII:016855979090053G?httpAccept=text/plain

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/0168-5597(90)90053-G

Electroencephalography and Clinical Neurophysiology

1 November 2022

published in

1 reference

22 April 2018

volume

77

1 reference

22 April 2018

issue

5

1 reference

22 April 2018

page(s)

323-329

1 reference

22 April 2018

Changes in the human visual evoked potential caused by the anticholinergic agent hyoscine hydrobromide: comparison with results in Alzheimer's disease

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0168-5597(90)90053-G

The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

1 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0168-5597(90)90053-G

Dopaminergic deficiency and delayed visual evoked potentials in humans

1 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0168-5597(90)90053-G

Distribution of cerebral degeneration in Alzheimer's disease. A clinico-pathological study

1 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0168-5597(90)90053-G

Visual evoked potentials in mild senile dementia of alzheimer type

1 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0168-5597(90)90053-G

Neurotransmitter-related enzymes in senile dementia of the alzheimer type

1 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0168-5597(90)90053-G

The meaning of cognitive impairment in the elderly

1 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0168-5597(90)90053-G

Development of a Rating Scale for Primary Depressive Illness

1 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0168-5597(90)90053-G

Primary presenile dementia: the use of the visual evoked potential as a diagnostic indicator.

1 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0168-5597(90)90053-G

A new clinical scale for the staging of dementia.

1 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0168-5597(90)90053-G

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0168-5597(90)90053-G

Visual evoked potentials in parkinsonism and dopamine blockade reveal a stimulus-dependent dopamine function in humans

1 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0168-5597(90)90053-G

Serial visual evoked potential recordings in Alzheimer's disease

1 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0168-5597(90)90053-G

Some morphometric aspects of the brain in senile dementia of the alzheimer type

1 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0168-5597(90)90053-G

Visual evoked response in senile and presenile dementia

1 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0168-5597(90)90053-G

Visual evoked potentials (VEPs) in senile dementia (Alzheimer type) and in non-organic behavioural disorders in the elderly; comparison with EEG parameters

1 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0168-5597(90)90053-G

Visual evoked potentials in elderly patients with primary or multi-infarct dementia

1 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0168-5597(90)90053-G

Presenile dementia—the use of the flash and pattern vep in diagnosis

1 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0168-5597(90)90053-G

The flash and pattern VEP as a diagnostic indicator of dementia

1 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0168-5597(90)90053-G

1 November 2022

Identifiers

1 reference

22 April 2018

1 reference

22 April 2018